Insider · CIK 0001507174

LaBarre Michael J.

CIK 0001507174 Name as filed on the most recent filing

Filed as LaBarre Michael J. (37)

70 transaction lines · from 37 filings · filed 2020-05-21 to 2025-02-27 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

70 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2025-02-27 S, Open-market sale Halozyme Therapeutics, Inc.HALO 2 lines 98,902, disposed Open Form 4 filing 0001415889-25-005899
2025-02-26 S, Open-market sale Halozyme Therapeutics, Inc.HALO 2 lines 581,244, disposed Open Form 4 filing 0001415889-25-005899
2025-02-25 S, Open-market sale Halozyme Therapeutics, Inc.HALO 2 lines 580,534, disposed Open Form 4 filing 0001415889-25-005899
2024-10-16 S, Open-market sale Halozyme Therapeutics, Inc.HALO 532,590, disposed Open Form 4 filing 0001415889-24-025233
2024-10-15 S, Open-market sale Halozyme Therapeutics, Inc.HALO 2 lines 537,469, disposed Open Form 4 filing 0001415889-24-025233
2024-09-18 S, Open-market sale Halozyme Therapeutics, Inc.HALO 2 lines 620,316, disposed Open Form 4 filing 0001415889-24-023657
2024-09-17 S, Open-market sale Halozyme Therapeutics, Inc.HALO 628,780, disposed Open Form 4 filing 0001415889-24-023657
2024-08-21 S, Open-market sale Halozyme Therapeutics, Inc.HALO 2 lines 617,470, disposed Open Form 4 filing 0001415889-24-021850
2024-08-20 S, Open-market sale Halozyme Therapeutics, Inc.HALO 610,550, disposed Open Form 4 filing 0001415889-24-021850
2024-07-24 S, Open-market sale Halozyme Therapeutics, Inc.HALO 551,150, disposed Open Form 4 filing 0001415889-24-020055
2024-07-23 S, Open-market sale Halozyme Therapeutics, Inc.HALO 2 lines 548,873, disposed Open Form 4 filing 0001415889-24-020055
2024-06-18 S, Open-market sale Halozyme Therapeutics, Inc.HALO 494,260, disposed Open Form 4 filing 0001415889-24-017625
2024-05-22 S, Open-market sale Halozyme Therapeutics, Inc.HALO 453,840, disposed Open Form 4 filing 0001415889-24-014123
2024-05-21 S, Open-market sale Halozyme Therapeutics, Inc.HALO 451,640, disposed Open Form 4 filing 0001415889-24-014123
2024-04-17 S, Open-market sale Halozyme Therapeutics, Inc.HALO 384,890, disposed Open Form 4 filing 0001415889-24-011058
2024-04-16 S, Open-market sale Halozyme Therapeutics, Inc.HALO 383,500, disposed Open Form 4 filing 0001415889-24-011058
2024-03-13 S, Open-market sale Halozyme Therapeutics, Inc.HALO 422,730, disposed Open Form 4 filing 0001415889-24-007825
2024-03-12 S, Open-market sale Halozyme Therapeutics, Inc.HALO 416,370, disposed Open Form 4 filing 0001415889-24-007825
2024-02-28 S, Open-market sale Halozyme Therapeutics, Inc.HALO 2 lines 395,463, disposed Open Form 4 filing 0001415889-24-005756
2024-02-27 S, Open-market sale Halozyme Therapeutics, Inc.HALO 399,460, disposed Open Form 4 filing 0001415889-24-005756
2024-01-17 S, Open-market sale Halozyme Therapeutics, Inc.HALO 360,000, disposed Open Form 4 filing 0001415889-24-001520
2024-01-16 S, Open-market sale Halozyme Therapeutics, Inc.HALO 360,000, disposed Open Form 4 filing 0001415889-24-001520
2023-12-13 S, Open-market sale Halozyme Therapeutics, Inc.HALO 403,940, disposed Open Form 4 filing 0001415889-23-016423
2023-12-12 S, Open-market sale Halozyme Therapeutics, Inc.HALO 2 lines 396,322, disposed Open Form 4 filing 0001415889-23-016423
2023-11-15 S, Open-market sale Halozyme Therapeutics, Inc.HALO 397,880, disposed Open Form 4 filing 0001415889-23-015195
2023-11-14 S, Open-market sale Halozyme Therapeutics, Inc.HALO 2 lines 390,790, disposed Open Form 4 filing 0001415889-23-015195
2023-10-17 S, Open-market sale Halozyme Therapeutics, Inc.HALO 365,200, disposed Open Form 4 filing 0001415889-23-014366
2023-09-19 S, Open-market sale Halozyme Therapeutics, Inc.HALO 390,980, disposed Open Form 4 filing 0001415889-23-013397
2023-08-22 S, Open-market sale Halozyme Therapeutics, Inc.HALO 2 lines 424,070, disposed Open Form 4 filing 0001415889-23-012570
2023-07-18 S, Open-market sale Halozyme Therapeutics, Inc.HALO 404,300, disposed Open Form 4 filing 0001415889-23-011318
2023-06-21 S, Open-market sale Halozyme Therapeutics, Inc.HALO 360,000, disposed Open Form 4 filing 0001415889-23-010180
2023-04-18 S, Open-market sale Halozyme Therapeutics, Inc.HALO 360,000, disposed Open Form 4 filing 0001415889-23-006740
2023-02-27 S, Open-market sale Halozyme Therapeutics, Inc.HALO 147,854, disposed Open Form 4 filing 0001415889-23-006738
2023-02-27 S, Open-market sale Halozyme Therapeutics, Inc.HALO 2 lines 495,483, disposed Open Form 4 filing 0001415889-23-003487
2023-02-16 S, Open-market sale Halozyme Therapeutics, Inc.HALO 141,770, disposed Open Form 4 filing 0001415889-23-002956
2023-02-15 S, Open-market sale Halozyme Therapeutics, Inc.HALO 483,940, disposed Open Form 4 filing 0001415889-23-002714
2023-01-17 S, Open-market sale Halozyme Therapeutics, Inc.HALO 2 lines 504,590, disposed Open Form 4 filing 0001415889-23-001128

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
Relationships on this page
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 70
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. LaBarre Michael J., insider transactions. Retrieved 2026-08-24 from https://ebomi.com/insider/0001507174

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.